Table 3.

Summary results of the subgroup analysis.

			Effect size		Heterogeneity
Coag. param.	Variable	Subgroups	k	SMD [95% CI]	I2 (%)	Tau-Squared	p-subgroup
PLT	Location						0.2123
		China	19	−0.2256 [−0.3747; −0.0764]	84.60	0.0694
		Other	15	−0.1384 [−0.3037; 0.0270]	73.60	0.0765
	Criteria						0.0263
		Guidelines	19	−0.1618 [−0.3319; 0.0082]	85.10	0.0983
		ICU	9	−0.1188 [−0.3056; 0.0680]	70.60	0.0308
		Aggravation	3	−0.0948 [−0.8750; 0.6854]	74.60	0.0682
		Oxygen therapy	3	−0.6834 [−1.4303; 0.0636]	0.00	0
DD	Location						0.3596
		China	23	0.7618 [0.5089; 1.0148]	94.70	0.3043
		Other	14	0.5992 [0.3204; 0.8780]	91.60	0.1964
	Criteria						0.0041
		Guidelines	22	0.6349 [0.4248; 0.8450]	92.10	0.1903
		ICU	12	0.9257 [0.5007; 1.3506]	96.70	0.4027
		Aggravation	3	0.2526 [−0.2458; 0.7510]	54.60	0.0182
FIB	Location						0.0813
		China	11	0.9393 [0.3154; 1.5632]	93.50	0.8093
		Other	11	0.4162 [0.1757; 0.6567]	74.50	0.0937
	Criteria						0.1560
		Guidelines	13	0.8539 [0.3128; 1.3949]	92.60	0.7496
		ICU	8	0.4510 [0.1690; 0.7330]	84.30	0.0814
		Aggravation	1	0.3031 [0.0253; 0.5809]	–	–
APTT	Location						0.8248
		China	13	0.2768 [0.0730; 0.4806]	88.30	0.0872
		Other	8	0.2499 [0.0661; 0.4337]	47.10	0.0169
	Criteria						0.3590
		Guidelines	16	0.2629 [0.1019; 0.4240]	84.70	0.0636
		ICU	4	0.3500 [−0.1307; 0.8306]	70.60	0.0520
		Aggravation	1	0.0714 [−0.2051; 0.3480]	–	–
PT	Location						0.9249
		China	16	0.2886 [0.1188; 0.4584]	81.80	0.0751
		Other	8	0.2745 [−0.0244; 0.5734]	78.30	0.1016
	Criteria						0.6332
		Guidelines	18	0.2889 [0.1401; 0.4377]	79.00	0.0628
		ICU	5	0.2992 [−0.2853; 0.8836]	87.60	0.1962
		Aggravation	1	0.1407 [−0.1360; 0.4175]	–	–